Veranda Learning Sln
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
25 04 2022 | Inter alia, to consider and approve : 1. To increase the Authorized Capital from Rs. 60cr to Rs.100cr 2. To Increase the Borrowing powers from Rs. 250cr to Rs. 1000cr. 3. To Increase the Investment Limits from Rs. 750cr to Rs. 1000cr. 4. To Consider potential acquisitions |
30 05 2022 | Audited Results |
13 08 2022 | Quarterly Results |
14 09 2022 | Preferential Issue of shares |
05 10 2022 | Inter alia, to consider and evaluate options for fund raising in the form of debt/debt instruments from international financial institutions/NBFCs and to finalise definitive documents to avail the funds for the acquisition of the identified targets. |
12 10 2022 | Inter alia, to Consider potential acquisition. |
12 11 2022 | Quarterly Results |
09 02 2023 | Quarterly Results |
29 05 2023 | Audited Results |
14 07 2023 | Preferential Issue of shares |
09 08 2023 | Quarterly Results |
07 09 2023 | General Purpose |
09 11 2023 | Quarterly Results |
07 02 2024 | Quarterly Results |
21 03 2024 | Inter alia, to consider and approve the Fund Raising by way of the issuance of senior, secured, redeemable, unlisted and unrated Non-Convertible Debentures (NCDs). |
14 11 2024 | Quarterly Results |
11 12 2024 | Preferential Issue of shares Inter alia, to consider and approve : 1. consider a proposal for fund raising by way of issue of equity shares/ warrants/ or any other equity linked instruments/ securities on a preferential basis in accordance with the Companies Act, 2013 read with the rules notified thereunder, and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, each as amended and such other acts, rules and regulations, as may be applicable, subject to any regulatory/ statutory approvals, as may be required and the approval of the shareholders of the Company. 2. consider prospective acquisitions that are synergistic with the current lines of business and approve the ancillary actions for the aforesaid matters, including the notice to shareholders for seeking their approval. |
11 02 2025 | Quarterly Results |
13 02 2025 | Quarterly Results (Revised) |
No News data available